missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LRRTM1 Polyclonal Antibody
Description
A suggested positive control is SK-N-SH cell lysate. PA5-21096 can be used with blocking peptide PEP-1210.
The Leucine-rich repeat transmembrane neuronal proteins (LRRTMs) are differentially expressed in the nervous system and were recently found to instruct presynaptic and mediate postsynaptic glutamatergic differentiation, with LRRTM1 and LRRTM2 most potent at inducing presynaptic differentiation. Each LRRTM protein is a type I transmembrane containing ten extracellular leucine-rich repeats and a short intracellular tail and has a developmentally regulated pattern distinct from all others. LRRTM1 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia.
Specifications
Specifications
| Antigen | LRRTM1 |
| Applications | Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | LRRTM1 |
| Gene Accession No. | D4A6D8, Q86UE6, Q8K377 |
| Gene Alias | 4632401D06Rik; AW125451; leucine rich repeat transmembrane neuronal 1; leucine-rich repeat transmembrane neuronal 1; leucine-rich repeat transmembrane neuronal 1 protein; leucine-rich repeat transmembrane neuronal protein 1; Lrrtm1; UNQ675/PRO1309 |
| Gene Symbols | LRRTM1 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?